Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/13/2008WO2008137137A1 Creatine ascorbyl derivatives and methods of use thereof
11/13/2008WO2008137134A2 Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
11/13/2008WO2008137128A2 Methods of treating fungal infections
11/13/2008WO2008137126A2 Combination therapy for the treatment of hcv infection
11/13/2008WO2008137107A1 Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions
11/13/2008WO2008137105A1 Method of treatment using fused aromatic compounds having anti-diabetic activity
11/13/2008WO2008137084A2 Diazaquinolones that inhibit prolyl hydroxylase activity
11/13/2008WO2008137081A1 Substituted ( 5, 6 ) -dihydronaphraalenyl compounds as reversible male contraceptives
11/13/2008WO2008137060A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008WO2008137048A1 Process for preparing aromatase inhibitors
11/13/2008WO2008137038A1 Locally active 'soft' antiandrogens
11/13/2008WO2008137012A1 Use of a glial attenuator to prevent amplified pain responses caused by glial priming
11/13/2008WO2008137010A1 Glycyrrhizic acid compounds as a foamer in chemically-derived surfactant-free dentifrice
11/13/2008WO2008137009A1 Liquorice extract antimicrobial and anti-inflammatory isolates
11/13/2008WO2008136976A2 Compounds for treating proliferative disorders
11/13/2008WO2008136948A1 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use
11/13/2008WO2008136906A1 Photosensitizers for targeted photodynamic therapy
11/13/2008WO2008136865A2 (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
11/13/2008WO2008136856A2 Resorbable pouches for implantable medical devices
11/13/2008WO2008136850A2 Cobalamin conjugates useful as imaging and therapeutic agents
11/13/2008WO2008136838A1 Novel amide derivatives of cddo and methods of use thereof
11/13/2008WO2008136791A1 Compositions comprising c-13 alkoxyether macrolide compounds and phenylpyrazole compounds
11/13/2008WO2008136759A1 Stabilized suspension
11/13/2008WO2008136756A1 Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
11/13/2008WO2008136754A1 Novel benzyl - 2 -oxo-piperazinyl/ 7-oxo/5-oxa- [1,4] diazepanyl/ 2 -oxo- tetrahydropyrimidinyl derivatives
11/13/2008WO2008136748A1 Tumour growth inhibitory compounds and methods of their use
11/13/2008WO2008136707A1 Ophthalmological gel and a method for the use thereof
11/13/2008WO2008136705A2 Drugs for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and a method for the use thereof
11/13/2008WO2008136695A1 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase
11/13/2008WO2008136642A1 Naphthoquinone-based pharmaceutical composition for treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
11/13/2008WO2008136519A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008WO2008136457A1 Nitrogen-containing aromatic derivative
11/13/2008WO2008136444A1 Fused heterocyclic derivative
11/13/2008WO2008136428A1 Nitrogen-containing five-membered heterocyclic compound
11/13/2008WO2008136397A1 Composition for prevention and/or treatment of peptic ulcer
11/13/2008WO2008136393A1 Crystal of lactam compound, and method for production thereof
11/13/2008WO2008136392A1 Preparation for oral administration
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008136377A1 Bicyclic heterocyclic compound
11/13/2008WO2008136374A1 Pharmaceutical composition for inhibiting peripheral neuropathy caused by the administration of anticancer agent
11/13/2008WO2008136331A1 BRANCHED α-GLUCAN, α-GLUCOSYLTRANSFERASE PRODUCING THE SAME, METHOD FOR PRODUCING THE SAME AND USE THEREOF
11/13/2008WO2008136324A1 Pyridine derivative substituted with heterocycle and phosphonoamino and antifungal agent containing the same
11/13/2008WO2008136213A1 Radiosensitivity-enhancing agent
11/13/2008WO2008136173A1 Adipocyte differentiation inhibitor containing stilbene derivative as active ingredient
11/13/2008WO2008136059A1 Composition for improving vascular endothelial function
11/13/2008WO2008136037A2 Chemical-catalytic method for the peracylation of oleuropein and its products of hydrolysis
11/13/2008WO2008136034A2 Ophthalmic compositions for the treatment of ocular hypertension and glaucoma
11/13/2008WO2008136018A2 4beta-amin0 podophyllotoxin congeners as potential anticancer agents and a process for the preparation thereof
11/13/2008WO2008136017A1 Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
11/13/2008WO2008136016A1 A stable controlled release oral solid dosage form composition and a process thereof
11/13/2008WO2008136012A1 Oral medicinal preparations
11/13/2008WO2008136010A1 A process for the preparation of highly pure imatinib base
11/13/2008WO2008136000A2 Compositions, articles and methods for preventing or reducing tobacco-associated damage
11/13/2008WO2008135984A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level
11/13/2008WO2008135980A1 Imatinib production process
11/13/2008WO2008135959A1 An exopolysaccharide
11/13/2008WO2008135886A2 Quinoline derivatives for use in the inhibition of the growth of tumour cells
11/13/2008WO2008135855A2 Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
11/13/2008WO2008135830A1 N- [6-amino-5- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
11/13/2008WO2008135829A2 Nanoparticles comprising cox-2 inhibitors and a non-ionizable polymer
11/13/2008WO2008135826A2 2 -pyridine carboxamide derivatives as sodium channel modulators
11/13/2008WO2008135824A1 Oxyalkylpyrazole compounds useful in therapy
11/13/2008WO2008135819A1 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide
11/13/2008WO2008135795A2 Polymorphic forms of bosentan
11/13/2008WO2008135793A1 Combination of aplidine and carboplatin in anticancer treatments
11/13/2008WO2008135792A1 Pm00104 compound for use in cancer therapy
11/13/2008WO2008135791A1 Imidazoquinolines with immuno-modulating properties
11/13/2008WO2008135786A1 Amino-thiazolyl- pyrimidine derivatives and their use for the treatment of cancer
11/13/2008WO2008135785A1 9- (pyrazol- 3 -yl) - 9h- purine-2 -amine and 3- (pyraz0l-3-yl) -3h-imidaz0 [4, 5-b] pyridin-5-amine derivatives and their use for the treatment of cancer
11/13/2008WO2008135767A1 New triazole compounds useful in the treatment of inflammation
11/13/2008WO2008135746A2 Natural bioactive compounds
11/13/2008WO2008135743A1 Substituted phosphonates and their use in decreasing amyloid aggregates
11/13/2008WO2008135674A2 Ibuprofen, cyclodextrines and ternary agent complexes, and pharmaceutical uses thereof
11/13/2008WO2008135661A2 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008WO2008135643A1 Composition having lipolytic activity, production method thereof and use of the composition.
11/13/2008WO2008135639A2 Novel useful inhibitors
11/13/2008WO2008135601A2 Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
11/13/2008WO2008135591A1 Novel benzamidine derivatives useful as potassium channel modulators
11/13/2008WO2008135578A1 Pyrazolo [3, 4-d] pyrimidine derivatives for the treatment of inflammation and/or allergic conditions
11/13/2008WO2008135557A1 Organic compounds
11/13/2008WO2008135548A1 Use of a naphtoic acid derivative in combination with red and/or blue light for treating acne vulgaris
11/13/2008WO2008135537A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
11/13/2008WO2008135527A2 Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
11/13/2008WO2008135526A1 Carboxylic acid amides as factor xa inhibitors
11/13/2008WO2008135525A2 Substituted azetidines, manufacturing and use thereof as medicaments
11/13/2008WO2008135524A2 Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
11/13/2008WO2008135522A1 Use of s1p receptor modulator
11/13/2008WO2008135488A1 Aspartyl protease inhibitors
11/13/2008WO2008135448A1 Beta-keto-amide derivatives useful as ion channel modulators
11/13/2008WO2008135447A1 Acetamide derivatives as potassium channel modulators
11/13/2008WO2008135442A1 Heterocyclic compounds and their use as pesticides
11/13/2008WO2008135413A1 Fungicidal pyridazines, method for the production thereof, and use thereof for controlling fungi and agents containing the same
11/13/2008WO2008135291A1 New progesterone receptor modulators
11/13/2008WO2008135263A1 Transdermal therapeutic system comprising remifentanil
11/13/2008WO2008135239A1 PHARMACEUTICAL COMPOSITION FOR INCREASING INSULIN SECRETION FROM PANCREATIC β-CELLS
11/13/2008WO2008135232A1 Use and compositions of purine derivatives for the treatment of proliferative disorders
11/13/2008WO2008135207A1 Implantable system for an intervertebral disc and intervertebral disc implant
11/13/2008WO2008135203A1 Slow release misoprostol for obstetric and/or gynaecological applications
11/13/2008WO2008135169A1 Nucleic acid-containing cosmetic and/or pharmaceutical preparations for treating epithelial tissue